Health TrialsbyHealthPanel

MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction

ConditionHFpEF - Heart Failure With Preserved Ejection Fraction
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania

About this trial

This is a three-arm, randomized, controlled trial to test the effectiveness of gamification plus a social incentive - either social support or competition - to increase adherence to physical activity among individuals with HFpEF. There will be a 2-week run-in period to obtain baseline measures of physical activity, followed by a 6-month intervention period and then a 3-month follow-up period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Gamification plus social incentive

    Behavioral

    Participants in the Gamification plus social incentive intervention arm will receive gamification and social incentives as part of the intervention. See arm descriptions for more detail.

  • Gamification plus competition

    Behavioral

    Participants in the Gamification plus competition intervention arm will receive gamification and a competition as part of the intervention. See arm descriptions for more detail.

Treatment groups

270 Participants
are divided into 3 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Gamification plus social incentiveExperimental treatment 1 intervention
Group C: Gamification plus competitionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

The primary outcome is the change in mean daily step counts from baseline through the 3-month post-intervention follow-up period.

The primary outcome is the change in mean daily step counts from baseline through the 3-month post-intervention follow-up period.

Time frame
9 months

Secondary outcomes

1

Change in mean daily steps from baseline to through the 6-month intervention period

Change in mean daily steps from baseline to through the 6-month intervention period

Time frame
6 months
2

Change in Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) score from baseline through the 6-month intervention period

Change in Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) score from baseline through the 6-month intervention period

Time frame
6 months
3

Change in Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) score from baseline through the 3-month post-intervention follow-up period

Change in Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) score from baseline through the 3-month post-intervention follow-up period

Time frame
9 months
4

Change in six-minute walk distance from baseline through the 6-month intervention period

Change in six-minute walk distance from baseline through the 6-month intervention period

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pennsylvania

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Source ClinicalTrials.gov
Apply now